Zheng Quan Shi Bao Wang·2025-05-23 10:11Group 1 - The innovative drug concept index rose by 0.97%, ranking 7th among concept sectors, with 116 stocks increasing in value [1] - Notable gainers included Hai Chen Pharmaceutical, which hit the daily limit with a 20% increase, and other companies like Xian Da Co., Zhong Sheng Pharmaceutical, and Hai Xiang Pharmaceutical also reached their daily limits [1] - The top gainers in the sector were Yang Guang Nuo He, Shu Tai Shen, and Bei Da Pharmaceutical, with increases of 12.55%, 11.77%, and 8.35% respectively [1] Group 2 - The innovative drug sector saw a net inflow of 438 million yuan, with 81 stocks receiving net inflows, and 5 stocks exceeding 100 million yuan in net inflows [2] - Hai Chen Pharmaceutical led the net inflow with 179 million yuan, followed by Zhong Sheng Pharmaceutical, Hua Hai Pharmaceutical, and Xian Da Co. with net inflows of 177 million yuan, 143 million yuan, and 110 million yuan respectively [2][3] - The net inflow ratios for Zhong Sheng Pharmaceutical, Xian Da Co., and Hai Chen Pharmaceutical were 42.93%, 17.67%, and 15.92% respectively [3] Group 3 - The innovative drug sector's performance was highlighted by the significant trading volume and turnover rates, with Hai Chen Pharmaceutical showing a turnover rate of 39.86% [3] - Other companies with notable turnover rates included Zhong Sheng Pharmaceutical at 3.92% and Hua Hai Pharmaceutical at 7.28% [3] - The overall market sentiment in the innovative drug sector appears positive, with several stocks experiencing substantial gains and strong capital inflows [2][3]